Wockhardt settles Entacapone patent and license agreement with Orion Corporation
Wockhardt Limited have uted the Entacapone patent settlement and license agreement with Orion Corporation in US.
Wockhardt Limited have uted the Entacapone patent settlement and license agreement with Orion Corporation in US.
Cadila Pharmaceuticals chooses TAKE Solutions for their PharmaReady eCTD, SPL and PPM software.
Arch Pharmalabs Ltd. received a new verification mark for a drug substance from US Pharmacopeia (USP) under the Pharmaceutical Ingredient Verification Program (PIVP) at their manufacturing facility in Gurgaon, India.
Marck Biosciences, a leading manufacturer and marketer of sterile dosages pharma products and Blow-Fill-Seal specialist, today announced its plan to enter the Singapore and Malaysian market.
In spite of new drugs available for treating Rheumatoid Arthritis, DMARDs are likely to remain as the preferred first line of therapy.
In a move that would prevent MNCs such as GlaxoSmithKline (GSK), Eli Lilly, Roche and Pfizer from selling their drugs at a huge premium in India, the government may soon finalise norms for monitoring prices of costly imported patented medicines for diseases such as diabetes, arthritis, obesity, cancer and heart diseases.
The Centre is planning to open 40
The department of pharmaceuticals (DoP) has received 76 applications from domestic drug makers who are interested in supplying generic medicines at a lower price to the generic drug stores (Jan Aushadhi Stores) recently being set up by the government in several states.
TCG Lifesciences Limited has been conferred with
Mid-sized pharma firm Elder Pharmaceuticals has tied up with Australian pharma firm Global Energy Medicines (GEM) to market the latter
Mumbai-based drugmaker Wockhardt is in discussions with ICICI Venture, ChrysCapital and other private equity firms to divest a 15% stake. The country
Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services, today announced that its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd. has received certificates of accreditation from the College of American Pathologists (CAP), a leading international laboratory accrediting organization, and the National Accreditation Board for Testing and Calibration Laboratories (NABL), the sole government-authorized laboratory accreditation body in India, for its diagnostic and clinical trials laboratory in Gurgaon, India.